PROM1 and hepatocellular carcinoma: CD133+ HCC CSCs were reported to be resistant to doxorubicin and 5-fluoruracil-mediated apoptosis because of their preferential expression of the survival proteins involved in the Akt/PKB and Bcl-2 pathway [21].